For research use only. Not for therapeutic Use.
Limaprost(CAT: I004763) is a prostaglandin E₁ (PGE₁) analog widely used in vascular and neurological research. It acts as a vasodilator and platelet aggregation inhibitor, enhancing blood flow and reducing thrombus formation. Limaprost is particularly valuable for studying conditions such as peripheral arterial disease, Buerger’s disease, and lumbar spinal stenosis. Its ability to improve microcirculation and mitigate ischemic damage makes it a useful tool for investigating therapeutic strategies for vascular and nerve-related disorders. Researchers also utilize Limaprost to explore the role of prostaglandins in inflammation and tissue repair.
Catalog Number | I004763 |
CAS Number | 74397-12-9 |
Synonyms | 17α,20-dimethyl-Δ2-PGE1;17α,20-dimethyl-Δ2-Prostaglandin E1 |
Molecular Formula | C22H36O5 |
Purity | ≥95% |
Target | PGE synthase |
Solubility | DMSO:40mg/mL |
Storage | -20°C |
IUPAC Name | (E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]hept-2-enoic acid |
InChI | CCCC[C@H](C)C[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCC/C=C/C(=O)O)O)O |
InChIKey | OJZYRQPMEIEQFC-UAWLTFRCSA-N |
SMILES | InChI=1S/C22H36O5/c1-3-4-9-16(2)14-17(23)12-13-19-18(20(24)15-21(19)25)10-7-5-6-8-11-22(26)27/h8,11-13,16-19,21,23,25H,3-7,9-10,14-15H2,1-2H3,(H,26,27)/b11-8+,13-12+/t16-,17+,18+,19+,21+/m0/s1 |